mechanisms underlying bronchial hyperresponsiveness are not fully understood and are believed to be primarily the consequence of in¯ammation or changes in smooth muscle physiology. From in vitro data it appears likely that serum immunoglobulin (Ig) E plays an important role in the induction of airway hyperreactivity, since passive sensitization of human airwaysÐi.e. the incubation of isolated bronchi from normal individuals with IgE-rich serumÐ increases non-speci®c responsiveness to histamine [5, 6] and induces speci®c responsiveness to allergen [7] in vitro. Moreover, circulating speci®c IgE antibodies in vivo cause airway responsiveness to the corresponding allergen in vitro [8] .
However, studies which looked for a relationship between in vivo parameters and histamine responsiveness of airway smooth muscle in vitro were inconclusive [9±15] . On the other hand, epidemiological studies indicate that high levels of total serum IgE correlate with impaired lung function [16] , increased prevalence of bronchial asthma [17] , and moreover, with bronchial hyperresponsiveness to histamine in vivo [18] . Until now, however, the role of total serum IgE levels in vivo for airway responsiveness to histamine in vitro has not been assessed.
To evaluate the role of circulating IgE for bronchial smooth muscle reactivity in vitro, we investigated whether in vitro airway reactivity in lung resection material from patients with elevated levels of serum IgE was increased as compared with patients with undetectable IgE. Therefore, we have analysed, retrospectively, those in vitro experiments on human bronchial ring preparations that have been performed in our laboratory (a) on airways obtained from patients with undetectable or with high serum IgE levels, (b) had passively sensitized and non-sensitized control tissues and (c) in which histamine concentration±effect curves had been constructed. Nineteen experiments (10 experiments in the low-IgE group with total serum IgE levels < 10 U/mL, nine experiments in the high-IgE group with total serum IgE levels > 200 U/mL) ful®lled the above criteria and were selected out of a total of 140 experiments to assess the effect of high circulating IgE levels on airway responsiveness in vitro.
Methods

Tissue preparation
Macroscopically normal bronchial tissue was obtained from 19 patients undergoing surgery for lung cancer. Serum IgE levels of all patients were determined on the day of surgery. In patients with high total serum IgE levels also speci®c IgE antibodies against house dust mite were measured.
Immediately after resection, peripheral airways (1±4 mm internal diameter) were dissected free of alveolar tissue and cut into rings (2±4 mm length). Tissues were rotated overnight at room temperature in tubes containing modi®ed Krebs buffer (composition: NaCl 118.4 mmol/L, KCl 4.7 mmol/L, MgSO 4 0.6 mmol/L, CaCl 2 1.3 mmol/L, KH 2 PO 4 1.2 mmol/L, NaHCO 3 25 .0 mmol/L, glucose 11.1 mmol/L) in the absence (non-sensitized controls) or presence of sensitizing serum (10% v/v). Sensitizing sera were prepared from the whole blood of 12 individuals demonstrating high total IgE (250 to > 3000 U/mL) and speci®c antibodies (FAST class $ 3) against allergen (Dermatophagoides farinae). Sera were not pooled but were frozen individually in 200±250-mL aliquots until required.
The next morning bronchial rings were transferred to 10-mL organ baths containing oxygenated (95% O 2 , 5% CO 2 ) modi®ed Krebs buffer (pH 7.4; 37 8C). Tissues were equilibrated for about 60 min at a resting tension of 300±400 mg, before the commencement of experimental protocols.
Tension measurements
All responses were recorded as changes in isometric tension (mg). At the beginning of each experiment a single dose of a b-adrenoceptor agonist, isoproterenol (1 mmol/L), was applied to determine the amount of inherent tone. After several washings and re-equilibration of the tissues, histamine concentration±effect curves within a range of 10 nmol/L À 0.3 mmol/L were constructed. In some experiments histamine concentration±effect curves were followed by allergen (D. farinae) concentration±effect curves within a concentration range of 0.03±30 U/mL. All concentration±effect curves were obtained in a cumulative manner, using incremental concentrations spaced at half log 10 intervals. At the end of the experiments, tissues' wet weights were recorded.
Measurements and analysis of results
All concentration±effect curves were acquired in at least one passively sensitized and one non-sensitized bronchial ring from the same donor. The potency of histamine was calculated from concentration±effect curves by non-linear curve-®tting for each individual tissue and expressed as the pEC 50 value (i.e. Àlog 10 of the concentration of histamine giving a half maximal effect). Histamine concentration± effect curves were compared between the different conditions (passively sensitized and non-sensitized, high and low IgE) using repeated-measures analysis of variance (ANOVA), with the different conditions as between±group factor and histamine concentration as within±group factor. In testing for statistically signi®cant differences between curves, we took into account the between±group effect (level) as well as its interaction with the within±group effect (slope). For the purpose of data presentation, curves were compared with each other at the different histamine concentrations using the paired or unpaired t-test, depending on the fact whether tissues were paired (sensitized vs non-sensitized) or not paired (high vs low IgE). Correspondingly, the parameters (maximal contraction and pEC 50 ) that had been estimated from the histamine concentration±effect curves were evaluated by ttests. The same approach as for histamine was followed in the analysis of allergen response curves. All values quoted are mean 6 SEM. The level of statistical signi®cance was assumed at P 0.05. t-tests were performed one-tailed regarding maximal contraction and pEC 50 and two-tailed otherwise.
Results
Tissue donors
Experiments on isolated airways from 19 patients were analysed. Nine patients showed total serum IgE levels above 200 U/mL (high-IgE group) and 10 patients levels below 10 U/mL (low-IgE group). In addition, seven patients of the high IgE group showed speci®c antibodies against house dust mite (D. farinae) of $ 0.2 U/mL or FAST class $ 1. In each group, two patients were diagnosed to have chronic obstructive pulmonary disease (COPD). One patient in the high-IgE group was known to be sensitized against house dust mite, but was asymptomatic. One patient in the low-IgE group had a known bronchial hyperresponsiveness to histamine (PC 20 FEV 1 0.2 mg/mL), impaired lung function (FEV 1 , 59% of predicted [19] ), a negative history of atopy and a negative skin prick test. All other patients showed a negative history of atopy and no other severe pulmonary disease other than lung cancer. Individual characteristics of the patients and mean values are given in Table 1 .
Baseline characteristics of bronchial rings
The number of ring preparations obtained from one patient ranged between 2 and 8 passively sensitized and 1±4 non-sensitized tissues; their mean values sum up to the given`n'-numbers. The wet weight (11.7 6 0.4 mg, n 19), resting tension (344 6 9 mg) and inherent tone (i.e. the magnitude of relaxation after a single dose of isoproterenol: 210 6 17 mg) showed no signi®cant differences either between passively sensitized and non-passively sensitized tissues or between tissues from high-and low-IgE donors.
Responses to histamine
Histamine caused concentration-dependent contractions in both non-passively sensitized and passively sensitized preparations in the high-IgE and the low-IgE group (Fig. 1 , Table 2 ). The concentration±effect curves obtained in non-passively sensitized tissues differed signi®cantly between both groups (ANOVA, P 0.002). Speci®cally, maximal contractions to histamine were increased in non-sensitized preparations from patients with IgE levels above 200 U/mL, as compared with non-sensitized airways from patients with IgE levels below 10 U/mL (P 0.03). The difference in potency of histamine between both groups did not reach statistical signi®cance (P 0.13).
In the low-IgE group, histamine concentration±effect curves were signi®cantly different between sensitized and non-sensitized tissues (ANOVA, P < 0.001). Passive sensitization of bronchi from patients with low IgE signi®cantly increased both the potency of histamine (P 0.017) and maximal contractions (P 0.003) obtained, as compared with non-sensitized tissues from the same individuals (Table 2 ). In contrast, in the high-IgE group, histamine concentration±effect curves did not differ signi®cantly between passively sensitized and non-sensitized tissues (ANOVA, not signi®cant; Table 2 and Fig. 1 ). Correspondingly, maximal contraction and pEC 50 were not different.
Furthermore, concentration±effect curves of both passively sensitized and non-passively sensitized tissues from the high-IgE group were almost identical to those of passively sensitized tissues in the low-IgE group (ANOVA, not signi®cant; Fig. 1) ; there was no signi®cant difference in potency or maximal contractions (Table 2) . 
Responses to allergen
Allergen (D. farinae) caused concentration-dependent contractions of passively sensitized tissues in the low-IgE group, but not in non-sensitized control tissues from the same donors; this difference was statistically signi®cant (ANOVA, P < 0.001, n 6; Fig. 2 ). In contrast, isolated airways from donors of the high-IgE group who showed speci®c antibodies against house dust mite demonstrated allergen-induced contractions in both passively sensitized and non-passively sensitized tissues. The concentration effect-curves differed signi®cantly from each other (ANOVA, P 0.003) and maximal contractions in non-passively sensitized tissues were about 50% of those obtained in sensitized tissues (P 0.04, n 5; Fig. 2 ). Concentration-response curves in non-passively sensitized tissues from the high-IgE group were signi®cantly different from the responses obtained in the non-sensitized tissues of the low-IgE group (ANOVA, P 0.002; Fig. 2 and Table 2 ). Correspondingly, maximal contractions were elevated (P 0.02).
Relationship between smoking status and bronchial reactivity
As the smoking status differed between the low and the high-IgE group, we additionally analysed our data with respect to the potential effect of current vs ex-smoking. There were 5/5 current/ex-smokers in the low-IgE and 8/1 in the high-IgE group, with a lower number of pack years in the latter group. In passively sensitized tissues of the lowIgE group, maximal contraction was signi®cantly higher in the current smokers than in the ex-smokers (P 0.04). The same was true in non-sensitized tissues (P 0.02). However, there was no difference in pEC 50 values, neither between sensitized nor between non-sensitized tissues of the current and ex-smokers from the low-IgE group. As the high-IgE group comprised 8/9 current smokers, the results of passive sensitization in current smokers did not differ from those of the whole group, in which passive sensitization led to a further increase in smooth muscle responsiveness.
Discussion
Our study demonstrates that total serum IgE is an in vivo determinant for airway smooth muscle hyperreactivity in vitro. Isolated airways from patients with high levels of total serum IgE were hyperresponsive to histamine in vitro as compared with airways from patients with low IgE levels. Furthermore, passive sensitization of airways from patients with elevated IgE levels did not lead to a further increase in histamine responsiveness. These results underline the important role of serum IgE for bronchial hyperreactivity and prove passive sensitization to be a useful in vitro model for non-speci®c airway hyperresponsiveness.
The approach which we used is based on previous reports that human airway smooth muscle preparations obtained from nonatopic individuals become hyperresponsive to histamine after incubation with IgE-rich serum, which is re¯ected in an increase in maximal contraction and a leftward shift of the concentration±effect curve of approximately a half log concentration [5±7]. Therefore, we hypothesized that patients whose airways had already been exposed to high levels of serum IgE in vivo should demonstrate airway hyperresponsiveness in vitro as compared with those with undetectable serum IgE levels. Indeed, our data revealed that smooth muscle preparations from patients with high serum IgE levels showed a signi®cant increase in concentration±effect curves and maximal contractions to histamine, neither of which could be further enhanced by passive sensitization. Furthermore, histamine responsiveness of non-passively sensitized airways from patients with high serum IgE levels was not different from that observed after passive sensitization of airways taken from patients with undetectable IgE levels. These ®ndings con®rm our hypothesis that the patients' serum, which contained high levels of total IgE, had already induced elevated or eveǹ maximal' non-speci®c responsiveness of airway smooth muscle before resection. These in vitro results ®t well with the positive correlation between serum IgE levels and bronchial responsiveness in vivo, which has been demonstrated in epidemiological studies in both adults and children [18,20±23] . Serum IgE level appear to be a marker of the immune responses that result in the development of airway hyperresponsiveness [24] or bronchial asthma [25] ; speci®cally, levels above 200 U/mL have been shown to be associated with airway hyperresponsiveness in vivo, independently of skin prick test reactions [22] . Our study demonstrates that circulating IgE levels are also predictors of non-speci®c bronchial responsiveness ex vivo.
The validity of our data is supported by the fact that passive sensitization with serum containing speci®c IgE antibodies induces airway responsiveness to the corresponding allergen, as known [7] , and are consistent with previous reports that bronchi from patients with high speci®c IgE antibodies contract in vitro when exposed to the corresponding allergen [8,26±28] . Interestingly, passive sensitization with serum containing higher concentrations of speci®c antibodies than that of tissue donors even further increased allergen-induced contraction in vitro.
It is known that the induction of allergen responsiveness through passive sensitization is dependent on speci®c IgE, [29] . In contrast with allergen responsiveness, however, the increase in histamine responsiveness after passive sensitization could be inhibited neither by pretreatment with anti-IgE antibodies [29] nor by depletion of serum IgE [30] . Conversely, incubation with IgE alone was not suf®cient to increase non-speci®c responsiveness to histamine in vitro [7] . Therefore, IgE-rich sera must contain a so far unknown factor that is closely linked both to IgE levels and to the ability of serum to induce histamine hyperresponsiveness [7] . Despite that, however, our data indicate that serum IgE could serve as a surrogate marker of the immunological processes that are linked to the development of non-speci®c airway hyperresponsiveness. From epidemiological studies it is known that not only atopy but also smoking can be associated with elevated total serum IgE levels [31, 32] . The observation that high IgE levels are related to current smoking and normalize after cessation of smoking [33±35] is consistent with our results. Furthermore, our data re¯ect the in vivo observations that (a) total serum IgE levels are associated with current smoking and (b) correlate with bronchial hyperresponsiveness. In addition, among nonatopic individuals, bronchial responsiveness occurs more frequently in current smokers as compared with non-or ex-smokers; however, in atopic subjects smoking does not lead to increased prevalence of airway responsiveness [36] . Although the relationship between current smoking and elevated levels of total IgE, as observed in epidemiological studies, is not fully understood [36, 37] , stimulation of TH2-type (interleukin-4) cytokine production by smoking may represent one mechanistic link [38±42]. Thereby, current smoking may be associated with the unknown serum factor that is linked to total IgE and causes non-speci®c airway responsiveness [7] . It is important to note that airway responsiveness in vitro could be enhanced by passive sensitization only in current smokers who showed low levels of circulating IgE, whereas in smokers with high IgE levels airway responsiveness in vitro could not be further increased. Although it is dif®cult to exclude smoking as a confounding factor in our study, this association between IgE levels and inducibility of airway hyperresponsiveness in vitro renders it unlikely that smoking was the primary cause of airway hyperresponsiveness. Therefore, the association between smoking and total IgE as observed in our study is consistent with our notion that it is the elevated IgE or rather the`unknown factor' level in vivo which is associated with airway hyperresponsiveness in vitro.
Previous studies which investigated the relationship between in vivo airway responsiveness, as determined by histamine inhalation challenges, and in vitro responsiveness of isolated airways, as determined by the potency of histamine (EC 50 ), have been inconclusive [10±15] and still it remains unresolved to what extent bronchial hyperresponsiveness in vivo results from in¯ammation, neural dysregulation, or intrinsic abnormality of airway smooth muscle. In vitro data obtained with passive sensitization demonstrate that airway hyperresponsiveness can be induced and modulated in isolated bronchial rings and that there is a close analogy between in vivo and in vitro ®ndings. Therefore, owing to the fact that the model of passive sensitization mimics important characteristics of airway hyperresponsiveness in vivo, it is rather unlikely that airway hyperresponsiveness in vivo results only from in¯ammation or neural dysregulation. In contrast, the relationship between airway hyperresponsiveness to histamine in vitro and exposure to IgE-rich serum in vivo is likely to re¯ect an abnormality of airway smooth muscle that is essential in the pathogenesis of airway hyperreactivity.
In summary, our study demonstrates that airways from patients with high levels of circulating IgE are hyperreactive to histamine in vitro. Therefore, total serum IgE is a predictor for non-speci®c airway hyperreactivity in vitro, in accordance with epidemiological studies, which show a link between serum IgE levels and bronchial hyperresponsiveness in vivo. Thus, it is likely that serum IgE or closely associated factors play a crucial role in the development of bronchial hyperreactivity under both in vivo and in vitro conditions. Since passive sensitization appears to be a model that closely mimics in vivo conditions, it remains to be seen, for example, whether therapeutic intervention with anti-IgE antibodies will not only alter allergen responses [43] but also non-speci®c hyperresponsiveness which could be of even greater relevance for the treatment of bronchial asthma.
